Have We Learned How to Talk About GLP1s?

KQED's Forum

KQED

News, Politics, News Commentary

4.2 • 726 Ratings

🗓️ 28 April 2026

⏱️ 52 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

An estimated one in eight Americans has now tried a GLP-1 medication like Ozempic or WeGovy: to lose weight, manage diabetes or experiment with anecdotal, off-label benefits. Yet GLP-1s can be hard to talk about — whether you want to ask someone if they take one, respond if you do, or discuss weight without dredging up unhealthy diet discourse. We’ll hear how you’re navigating these conversations in the age of GLP-1s. Tell us: How are GLP-1s showing up in your world? Guests: Diana Thiara, medical director, UCSF Weight Loss Management Program Whitney Casares, pediatrician; author, “Raising Body-Confident Kids” and “My One-Of A-Kind Body: The Ultimate Guide to Caring for Me” Angela Corral, senior editor, KQED’s The California Report; she has been been taking a GLP-1 for almost 2 years Learn more about your ad choices. Visit megaphone.fm/adchoices

Transcript

Click on a timestamp to play from that location

0:00.0	Support for KQED Podcasts comes from San Francisco International Airport.
0:05.4	Mark Twain's coldest winter is right around the corner.
0:08.3	Luckily, SFO has nonstop flights to over 140 destinations worldwide to help you get some summer sunshine.
0:15.4	More info at flysfo.com slash nonstop.
0:19.7	Support for KQED podcasts comes from Landmark College, offering executive function support
0:25.6	and social coaching for neurodivergent individuals at the Bay Area Success Center.
0:31.1	Learn more at landmark.edu slash success center.
0:36.4	From KQED.
0:39.0	Welcome to Forum.
0:40.3	I'm Enoch Kim.
0:41.5	With an estimated one in eight Americans trying GLP-1s like OZempic or Rigovi, drugs known for weight loss, though they have other uses, many have been wondering how to talk about it without dredging up the worst parts of diet culture,
0:55.0	like glorifying thinness or treating weight loss as solely about willpower.
0:59.0	This hour, we'll hear how you're navigating these conversations, especially as GLP-1s are now being tried for many diseases and conditions beyond weight management,
1:08.0	including addiction, arthritis, brain fog, or migraines.
1:11.9	Listeners, how are GLP1 showing up in your life? And have you found it hard to talk about?
1:16.9	You can tell us by calling 866-733-6786 posting on our social channels or emailing forum
1:23.2	at KQED.org. Joining me first is Dr. Whitney Casares, a pediatrician and author who takes a GLP1, and was
1:31.3	featured in a January time story titled, Can I Ask Someone if they're On Ozempic?
1:36.8	Dr. Casas, welcome to Forum.
1:39.0	Thank you for having me.
1:40.3	In that time article, you share the story of a mom at your daughter's school asking you if you were on a GLP1.
1:46.7	And it didn't feel so great the way she did it.
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from KQED, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of KQED and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.